LifeVest Trends Validation Protocol

CompletedOBSERVATIONAL
Enrollment

198

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Heart Failure
Interventions
DEVICE

Trends-equipped LifeVest 4000

LifeVest 4000 monitors patients for VT/VF, notifies the patient if VT/VF occurs, and instructs them to press response buttons. In unresponsive patients, LifeVest delivers defibrillation therapy. Trends modifications for heart failure monitoring include: body position data collection; heart rate measurements, activity data collection; ability to perform a health survey; ability to guide patients through a walk test

Trial Locations (21)

8036

Klinische Abteilung für Kardiologie, Graz

11203

SUNY Downstate, Brooklyn

23454

VA Beach General, Virginia Beach

25304

CAMC, Charleston

25702

St. Mary's Medical Center, Huntington

30046

Gwinnett Medical Center, Lawrenceville

33432

Cardiac Arrhythmia Service, Boca Raton

37403

Erlanger Clinical Research, Chattanooga

38104

Methodist Healthcare Foundation, Memphis

40503

Lexington Cardiology Consultants, Lexington

48507

Cardiology Institute of Michigan, Flint

50733

St. Vinzenz Hospital, Cologne

53105

Medizinische Klinik & Poliklinik II - Kardiologie, Bonn

73120

Oklahoma Heart Hospital, Oklahoma City

78052

Klinik für Innere Medizin III, Villingen-Schwenningen

79189

Universitats-Herzzentrum Freiburg - Bad Krozingen, Bad Krozingen

92868

Orange County Heart Institute, Orange

96450

Klinikum Coburg, Coburg

98122

Swedish Medical Center, Seattle

Unknown

Kerckhoff-Klinik, Bad Nauheim

Department für Herzinsuffizienz und Devicetherap, Hamburg

All Listed Sponsors
lead

Zoll Medical Corporation

INDUSTRY

NCT02149290 - LifeVest Trends Validation Protocol | Biotech Hunter | Biotech Hunter